Brown Advisory
ITCI

Brown Advisory’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Brown Advisory’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,147
Closed -$283K – 1412
2025
Q1 		$283K Sell
2,147
-2,114
-50% -$263K ﹤0.01% 1153
2024
Q4 		$356K Buy
+4,261
New +$350K ﹤0.01% 1108

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brown Advisory's ITCI Position: Q2 2025 in Review

Brown Advisory sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,147 shares — an estimated $283K sold.

Brown Advisory first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $356K in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Brown Advisory reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Brown Advisory sold 2,147 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $283K.
  • Brown Advisory first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
  • Brown Advisory's Intra-Cellular Therapies Inc. position peaked at $356K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Brown Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.